FDA and CMS work to prevent regulatory conflict as states pursue AI testing in clinical settings
Source Summary
Federal health regulators are engaging in behind-the-scenes discussions to prevent a regulatory conflict between states and the federal government over AI oversight in clinical settings. Multiple states are moving forward with plans to test artificial intelligence in healthcare environments, creating potential friction with existing FDA and CMS authority.
Why it matters
Uncoordinated state and federal AI regulation in healthcare could create compliance uncertainty for developers and inconsistent patient protections across jurisdictions.
What remains uncertain
The specific nature and timeline of the regulatory conflict, and the outcome of federal-state coordination efforts, remain unspecified in the source.
